Skip to search formSkip to main contentSkip to account menu

esproquin

Known as: 2-(3-ethylsulfinylpropyl)-1,2,3,4-tetrahydroisoquinoline, Esproquine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Isoquinolines

Narrower (1)

NC 7197

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: Evidence for antidopaminergic properties of some alpha antagonists
The effects on dopamine (DA) metabolism, on3H-spiperone binding and on amphetamine-induced stereotypies of a variety of drugs… 
1979
1979
Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of α-adrenolytic drugs
SummaryThe effects of various α-adrenoceptorblocking drugs on the depression of exploratory activity (ambulation and rearing… 
1973
1973
Positive inotropic effect of oral esproquin in normal subjects
The Hypertension and Glinical Hemodynamics Section, Veterans Administratian Hospital, and the Department of Medicine, Georgetown… 
1973
1973
Efficacy of short term oral administration of a new inotropic drug (Esproquin) in congestive heart failure
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)